SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA
SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA Standard Operating Procedure for Stability Study Documentation for NDAs 1) Purpose The purpose of this SOP is to provide a standardized procedure for documenting stability studies in support of New Drug Applications (NDAs) to the US FDA to ensure compliance with…
Read More “SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA” »
